An NSF International Company EU-Israel ACAA
Tuesday the 30th October 2012
On 23 October the European Parliament voted 379-230 with 41 abstaining in support of the Agreement on Conformity Assessment and Acceptance of Industrial Products (ACAA) between the EU and Israel. Medicinal products certified in the EU will be considered certified in Israel and vice versa under this agreement, which is a protocol to the 1995 EU-Israel Association Agreement. It will apply to all pharmaceuticals except for advanced therapy products, special medicinal products based on tissues and cells of human origin, and medicinal products that include blood products.
An ACAA is a ‘super’ MRA, so will mean that imports from Israel will be able to be exempt from the need for re-testing on importation. The implementation date for this ACAA is not yet known.
